MyOme Introduces Groundbreaking Test for Prostate Cancer Risk Assessment MyOme has launched an integrated polygenic risk score test, enhancing the early detection of prostate cancer through genomic modeling and individualized risk assessments.

MyOme Introduces Groundbreaking Test for Prostate Cancer Risk Assessment #USA #Menlo_Park #Prostate_Cancer #MyOme #genomic_risk